Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

Chronic inflammation may be quietly reshaping the colon and making it more vulnerable to early-onset colorectal cancer. Scientists found that colon tissue in younger patients was stiffer, even in ...

A new study suggests that long-term inflammation may physically change the colon in ways that promote early-onset colorectal cancer (CRC). Researchers ...

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by growing awareness and testing.

Scientists identify a protein linked to bowel and liver cancers that could lead to safer, targeted treatments as cases rise, ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...